Surgical approaches to locally advanced non-small-cell lung cancer

Clinical Pulmonary Medicine

Volumn 4, Issue 5, 1997, Pages 273-282

  Ginsberg, Robert J ^a,b   Weigel, Tracy ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Combined modality treatment; Locally advanced disease; Non small cell lung cancer; Surgical therapy

Indexed keywords

ADVANCED CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; REVIEW; SURGICAL APPROACH;

EID: 0030967750     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199709000-00004     Document Type: Review

References (98)

1. American Cancer Society. Cancer facts and figures, 1997. Atlanta, GA: American Cancer Society, 1997.
2. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96: 440-7.
3. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(4 Suppl):225S-233S.
4. Ginsberg RJ, Vokes E, Raben A. Non-small cell lung cancer. Lung cancer. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 5th ed. Philadelphia: JB Lippincott, 1996:858-911.
5. Luketich JD, Van Raemdonck DE, Ginsberg RJ. Extended resection for higher stage non-small cell lung cancer. World J Surg 1993;17: 719-28.
6. Thomas P. Role of mediastinal staging of lung cancer. Chest 1994;106(6 Suppl):331S-333S.
7. Ginsberg RJ, Rubinstein LV, for the Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60:615-23.
8. Izbicki JR, Thetter O, Habekost M, et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 1994;81:229-35.
9. Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 1992;54:460-6.
10. Non-Small Cell Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta analysis using updated data on individual patients from 52 randomized clinical trials BMJ 1995;311:899-909.
11. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. J Natl Cancer Inst 1994;86:673-80.
12. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994;330:153-8.
13. Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992;53:992-8.
14. Albain KS. Induction therapy followed by definitive local control for stage III non-small cell lung cancer. A review, with a focus on recent trimodality trials. Chest 1993;103(1 Suppl):43S-50S.
15. Martini N, Kris MG, Flehinger BJ, et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993;55:1365-74.
16. Albertucci M, DeMeester TR, Rothberg M, Hagen JA, Santoscoy R, Smyrk TC. Surgery and the management of peripheral lung tumors adherent to the parietal pleura. J Thorac Cardiovasc Surg 1992;103:8-13.
17. McCaughan BC. Primary lung cancer invading the chest wall. Chest Surg Clin N Am 1994;4:17-28.
18. Pancoast HK. Superior pulmonary sulcus tumors. Tumor characterized by pain, Homer's syndrome, destruction of bone and atrophy of hand muscles. JAMA 1932,99:1391-6.
19. Chardack WM, MacCallum JD. Pancoast tumor: five year survival without recurrence or metastases following radical resection and postoperative irradiation. J Thorac Surg 1956; 31:535-42.
20. Shaw, et al. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961;154:29-40.
21. Paulson DL. Carcinomas in the superior pulmonary sulcus. J Thorac Cardiovasc Surg 1975;70:1095-104.
22. Martini N, Ginsberg RJ. Surgical management of lung cancer. In: Pearson FG, Deslauriers J, Ginsberg RJ, Hiebert CA, McKneally MF, Urschel HC, editors. Thoracic surgery. VI. New York: Churchill Livingstone, 1995:690-705.
23. Ginsberg RJ, Martini N, Zaman M, et al. The influence of surgical resection and intraoperative brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg 1994;57: 1440-5.
24. Faber LP. Results of surgical treatment of stage III lung carcinoma with carinal proximity. The role of sleeve lobectomy versus pneumonectomy and the role of sleeve pneumonectomy. Surg Clin North Am 1987;67:1001-14.
25. Mathisen DJ, Grillo HC. Carinal resection for bronchogenic cancer. J Thorac Cardiovasc Surg 1991;102:16-23.
26. Dartevelle PG, Chapelier AR, Pastorino U, et al. Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors. J Thorac Cardiovasc Surg 1991;102:259-65.
27. Dartevelle PG, Macchiarini P, Chapelier AR. 1986: tracheal sleeve pneumonectomy for bronchogenic carcinoma: report of 55 cases. Updated in 1995. Ann Thorac Surg 1995;60: 1854-5.
28. Burt ME, Pomerantz AH, Bains MS. Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am 1987;67:987-1000.
29. Martini N, Yellin A, Ginsberg RJ, et al. Management of non-small cell lung cancer with direct mediastinal involvement. Ann Thorac Surg 1994;58:1447-51.
30. Van Raemdonck DE, Schneider A, Ginsberg RJ. Surgical treatment for higher stage non-small cell lung cancer - "a collective review." Ann Thorac Surg 1992;54:999-1013.
31. Pearson FG, DeLarue NC, Ilves R, Todd TR, Cooper JD. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 1982;83:1-11.
32. Weisenburger TH. Effects of postoperative mediastinal radiation on completely resected stage II and stage II epidermoid cancer of the lung. LCSG 773. Chest 1994;106(6 Suppl): 297S-301S.
33. Niiranen A, Nitamo-Korhonen S, Kouri M, et al. Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: a randomized study. J Clin Oncol 1992;10:1927-32.
34. Wada H, Hitomi S, Teramatsu T, and the West Japan Study Group for Lung Cancer Surgery. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J Clin Oncol 1996;14:1048-54.
35. Shepherd FA. Non-small-cell lung cancer: chemotherapy. In: Pearson FG, editor. Thoracic surgery. New York: Churchill Livingstone, 1995:707-23.
36. Perez CA, Stanley K, Grundy G. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group. Cancer 1982;50:1091-9.
37. Dartevelle P, Macchiarini, Chapelier A. Resection for T0/4 non-small-cell lung cancer. In: Mota G, editor. Lung cancer: frontiers in science and treatment. Italy: Gratica LP, 1994: 449-58.
38. Rusch VW, Albain KS, Crowley JJ. Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology Group. Ann Thorac Surg 1994;58:290-5.
39. Albain KS, Rusch VW, Crowley JJ. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group Phase II Study 8805. J Clin Oncol 1995;13:1880-92.
40. Hata, et al. Resection of N2/N3 mediastinal disease. In: Mota G, editor. Lung cancer: frontiers in science and treatment. Italy: Gratica LP, 1994:431-44.
41. Cox JD, Azarnia N, Byhardt RW, et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2: possible survival benefit with >69.6 Gy in favorable patients with stage III non-small-cell lung cancer: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990;8:1543-55.
42. Dillman RO, Seagran SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990;323:940-5.
43. Schaake-Koning C, Van Den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992;326:524-30.
44. Burt M, Wronski M, Arbit E, Galicich JH. Resection of brain metastases from non-small cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff. J Thorac Cardiovasc Surg 1992;103:399-411.
45. Deslauriers J, Brisson J, Cartier R, et al. Carcinoma of the lung. Evaluation of satellite nodules as a factor influencing prognosis after resection. J Thorac Cardiovasc Surg 1989;97: 504-12.
46. Shimizu N, Ando A, Date H, Teramoto S. Prognosis of undetected intrapulmonary metastases in resected lung cancer. Cancer 1993; 71:3868-72.
47. Paone JF, Spees EK, Newton CG, et al. An appraisal of en bloc resection of peripheral bronchogenic carcinoma involving the thoracic wall. Chest 1982;81:203-7.
48. Patterson GA, Ilves R, Ginsberg RJ, et al. The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. Ann Thorac Surg 1982;34:692-7.
49. Piehler JM, Pairolero PC, Weiland LH, et al. Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en bloc resection. Ann Thorac Surg 1982;34:684-91.
50. McCaughan BC, Martini N, Bains MS, McCormack PM. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications. J Thorac Cardiovasc Surg 1985;89:836-41.
51. Van de Wal HJ, Lacquet LK, Jongerius CM. Chirurgische behandeling van longtumoren met doorgroei in de thorax. Tijdschr Geneeskd (Belg) 1987;43:91-6.
52. Allen MS, Mathisen DJ, Grillo HC, et al. Bronchogenic carcinoma with chest wall invasion. Ann Thorac Surg 1991;51:948-51.
53. Paulson DL. The "superior sulcus" lesion. In: Delarue NC, Eschapasse H. International trends in general thoracic surgery, vol. 1. Lung cancer. Philadelphia: Saunders, 1985:121-31.
54. Anderson TM, Moy PM, Homes EC. Factors affecting survival in superior sulcus tumors. J Clin Oncol 1986;4:1598-603.
55. Devine JW, Mendenhall WM, Million RR, Carmichael MJ. Carcinoma of the superior sulcus treated with surgery and/or radiation therapy. Cancer 1986;57:941-3.
56. Rice TW, Pringle JF, Sinclair JE, et al. Superior sulcus tumors; results of treatment [abstract]. Lung Cancer 1986;2:156-7.
57. Shahian DM, Neptune WB, Ellis FH Jr. Pancoast tumors: improved survival with preoperative and postoperative radiotherapy. Ann Thorac Surg 1987;43:32-8.
58. McKneally M. Discussion of Shahian DM, Neptune WB, Ellis FH. Pancoast tumors: improved survival with preoperative and postoperative radiotherapy. Ann Thorac Surg 1987;43:32-8.
59. Ricci C, Rendina EA, Venula F. Surgical treatment of superior sulcus tumors [abstract]. Lung Cancer 1988;4(Suppl):A95.
60. Carrel T, Nachbur B, Bleher A. Is radiotherapy prior to surgical resection indicated for bronchogenic carcinoma with chest wall infiltration and for Pancoast tumors? [abstract] Lung Cancer 1988;4:A80.
61. Komaki R, Mountain CF, Holbert JM, et al. Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (MO) at presentation. Int J Radiat Oncol Biol Phys 1990;19:31-6.
62. Ginsberg RJ, Martini N, Zaman M, et al. The influence of surgical resection and intraoperative brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg 1994;57: 1440-5.
63. Van Den Bosch JMM, Bergstein PGM, Laros CD, Gelissen HJ, Schaepkens van Riempst ALEMS, Wagenaar SjSc. Lobectomy with sleeve resection in the treatment of tumors of the bronchus. Chest 1991;80:154-7.
64. Ungar I, Gyeney I, Scherer E, Szarvas I. Sleeve lobectomy: an alternative to pneumonectomy in the treatment of bronchial carcinoma. Thorac Cardiovasc Surg 1981;29:41-6.
65. Eschapasse H. Proceedings of the minisymposia of the IV world conference on lung cancer, Toronto, Canada, 1985.
66. Keszler P. Sleeve resection and other bronchoplasties in the surgery of bronchogenic tumors. Int Surg 1986;71:229-32.
67. Maeda M, Nanjo S, Nakamura K, Nakamoto K. Tracheobronchoplasty for lung cancer. Int Surg 1986;71:221-8.
68. Vogt-Moykopf I, Fritz T, Meyer G, et al. Bronchoplastic and angioplastic operation in bronchial carcinoma: long term results of a retrospective analysis from 73-83. Int Surg 1986;71: 211-20.
69. Naruke T. Bronchoplastic and bronchovascular procedures of the tracheobronchial tree in the management of primary lung cancer. Chest 1989;96(1 Suppl):53S-56S.
70. Naruke T, Goya T, Tsuchiya R, Suemasu K. The importance of surgery to non-small cell carcinoma of the lung with mediastinal lymph node metastasis. Ann Thorac Surg 1988;46: 603-10.
71. Levasseur PH, Regnard JF. Long term results after surgery for N2 non-small cell lung cancer. Presented at the IASLC workshop, 17-21 June 1990, Bruges, Belgium.
72. Watanabe Y, Shimizu J, Oda M, et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg 1991;51: 253-61.
73. Walker WS, Carey F, Cameron EWJ, Lamb D. Results of surgery for N2 status bronchial carcinoma. Presented at the IASLC workshop, 17-21 June 1990, Bruges, Belgium.
74. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67: 1037-49.
75. Mountain CF. The biological operability of stage in non-small cell lung cancer. Ann Thorac Surg 1985;40:60-4.
76. Miller LD, McManus KG, Allen MS, et al. Results of surgical resection in patients with N2 non-small cell lung cancer. Ann Thorac Surg 1994;57:1095-101.
77. Goldstraw P, Mannam GC, Kaplan DK, Michail P. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease) J Thorac Cardiovasc Surg 1994;107:19-28.
78. Pearson FG, Delarue NC, Ilves R, et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 1982;83:1-11.
79. Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg 1985;40:556-60.
80. Pisters K, Kris M, Gralla R, et al. Preoperative chemotherapy in stage IIIA non-small cell lung cancer: an analysis of a trial in patients with clinically apparent mediastinal node involvement. In: Salmon CG, editor. Adjuvant therapy of cancer. 6th ed. Philadelphia: Saunders, 1990:133-7.
81. Burkes R, Ginsberg R, Shepherd F, et al. Neoadjuvant trial with MVP (mitomycin-C + vindesine + cisplatin) chemotherapy for stage III (T1-3, N2 M0) unresectable non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1989;8:221.
82. Fossella F, Ryan B, Dhingra H et al: Interim report of a prospective randomized trial of neoadjuvant chemotherapy plus surgery vs surgery alone for IIIA non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol Annu Meet 1991;10:240.
83. Faber L, Kittle C, Warren W, et al. Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 1989;47:669-77.
84. Weiden P, Piantadosi S. Preoperative chemoradiotherapy in stage III non-small cell lung cancer (NSCLC): a phase II study of the lung study group (LCSG). Proc Am Soc Clin Oncol Annu Meet 1988;7:197.
85. Eagan R, Ruud C, Lee R, et al. Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer. Cancer Treat Rep 1987;71:895-900.
86. Strauss G, Sherman L, Mathisen D, et al. Concurrent chemotherapy (CT) and radiotherapy (RT) followed by surgery (S) in marginally resectable stage IIIA non-small cell carcinoma of the lung (NSCLC): a cancer and leukemia group B study. Proc Am Soc Clin Oncol Annu Meet 1988;7:203.
87. Albain K, Rusch V, Crowley J, et al. Concurrent cisplatin (DDP), VP-16, and chest irradiation (RT) followed by surgery for stages IIIa and IIIb non-small cell lung cancer (NSCLC): a Southwest Oncology Group (SWOG) Study (#8805). Proc Am Soc Clin Oncol Annu Meet 1991;10:244.
88. Skarin A, Jochelson M, Sheldon T, et al. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: Long-term follow-up in 41 patients. J Surg Oncol 1989;40:266-74.
89. Sherman D, Strauss G, Schwartz, et al. Combined modality therapy for regionally advanced stage III non-small cell carcinoma of the lung (NSCLC) employing neo-adjuvant chemotherapy (CT), radiotherapy (RT), and surgery (S). Proc Am Soc Clin Oncol Annu Meet 1989;6:167.
90. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. J Natl Cancer Inst 1994;86:673-80.
91. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994;330:153-8.
92. Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992;53:992-8.
93. Jensik RJ, Faber LP, Kittle CF, Miley RW, Thatcher WC, El-Baz N. Survival in patients undergoing tracheal sleeve pneumonectomy for bronchogenic carcinoma. J Thorac Cardiovasc Surg 1982;84:489-96.
94. Faber LP. Results of surgical treatment of stage III lung carcinoma with carinal proximity. The role of sleeve lobectomy versus pneumonectomy and the role of sleeve pneumonectomy. Surg Clin North Am 1987;67:1001-14.
95. Dartevelle PG, Khalife J, Chapelier A, et al. Tracheal sleeve pneumonectomy for bronchogenic carcinoma: report of 55 cases. Ann Thorac Surg 1988;46:68-72.
96. Tsuchiya R, Goya T, Naruke T, Suemasu K. Resection of tracheal carina for lung cancer. J Thorac Cardiovasc Surg 1991;99:779-87.
97. Vogt-Moykopf I, Meyer G, Naunheim K, et al. In: Baue AE, Geha AS, Hammond GL, Luks H, Naunheim KS, editors. Glenn's thoracic and cardiovascular surgery. 5th ed. Stamford, CT: Appleton & Lange, 1991:403-17.
98. Mathisen DJ, Grillo HC. Carinal resection for bronchogenic cancer. J Thorac Cardiovasc Surg 1991;102:16-23.